Seminar Briefing
Seminar Briefings are concise summaries of the presentations and discussions at seminars and conferences organised by OHE.
Can the US Afford to Ignore Cost-effectiveness Evidence?
1 March 2014
Cost-effectiveness analysis plays a limited role in US health care compared to many other countries. In this Seminar Briefing, Dr James Chambers, Center for the Evaluation…
Value Based Pricing in Sweden: Lessons for Design?
11 January 2012
In this Seminar Briefing, Ulf Persson recounts Sweden’s experience with its approach to value based pricing (VBP). The model is a flexible approach that gives weight…
Is There a Productivity Crisis in Pharmaceutical R&D?
6 January 2012
This Seminar Briefing recounts the key points made by Prof Riccaboni, from the University of Trento, at a recent OHE Lunchtime Seminar. It focuses primarily on…
Summary Report of the OHE/EFPIA Antibacterial Roundtable
1 November 2011
Antibacterial drug resistance is a serious and growing worldwide problem that threatens our ability to cure traditionally treatable diseases and to successfully perform numerous surgical procedures…
Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?
1 November 2011
Because health care resources always are scarce, decisions about what (and what not) to pay for cannot be avoided. Deciding how to value health and aspects of…
Priority Review Vouchers to Encourage Innovation for Neglected Diseases
1 January 2011
Priority Review Vouchers (PRVs) are awarded in the US to companies that gain approval there for a new drug for one of sixteen tropical diseases, under…
Science Policy Research: Having an Impact on Policy?
1 December 2010
Professor Ben Martin (Science and Technology Policy Studies at SPRU, University of Sussex) defines science policy research as ’economic, policy, management and organisational studies of science,…
Innovation in Medicines: Can We Value Progress?
1 August 2010
Summarised in this publication are the main points and conclusions from a discussion facilitated by OHE that focused on innovation in the pharmaceutical industry. Participants included…
Mental Health Economics and Policy in a Global Context
1 December 2003
The purpose of the conference was to locate and promote the role of health economics in mental health policy in low and middle income countries. Health…